Wound healing is a dynamic and tightly regulated cascade. After the initial clot formation and inflammatory response, the wound transitions into the proliferative phase. This phase is characterized by the formation of new tissue to fill the wound defect. Key cellular and molecular events include angiogenesis (the formation of new blood vessels), extracellular matrix (ECM) remodeling, and the proliferation and migration of fibroblasts and epithelial cells [1]. The primary goal of care during this phase is not to fight infection or remove debris, but to create an optimal environment that supports these constructive, energy-intensive processes.
The wound described is a stage 2 pressure ulcer, which involves partial-thickness skin loss. In the proliferative phase, the wound bed is typically clean, moist, and red or pink, with the formation of granulation tissue. Interventions must be tailored to protect this fragile new tissue and provide the systemic resources needed for continued repair.
Option 2: Ensure adequate nutrition to support tissue repair. This is the most appropriate intervention. The proliferative phase is an anabolic state with high metabolic demand. Fibroblasts require amino acids to synthesize collagen, the primary structural protein of the ECM, and cells undergoing rapid division need energy and micronutrients. The referenced literature underscores that healing involves "extracellular matrix remodeling" and "coordinated cellular responses" [1], all of which are protein-synthesis-dependent activities. Without adequate nutrition, particularly sufficient protein and calories, the healing cascade stalls because the body lacks the fundamental building blocks for tissue regeneration. This systemic support is a cornerstone of nursing care for any client with a healing wound.
Option 1: Apply antimicrobial dressing to prevent infection. While preventing infection is always a consideration, a non-infected wound in the proliferative phase does not routinely require an antimicrobial dressing. The body's own immune defenses, having moved past the inflammatory phase, are managing the local bacterial load. Unnecessary use of antimicrobials can be cytotoxic to the very fibroblasts and new epithelial cells we are trying to support, potentially disrupting the "tightly regulated healing cascade" [1]. This intervention is a higher priority during the inflammatory phase or for a clinically infected wound.
Option 3: Debride necrotic tissue from the wound bed. Debridement is a critical intervention for wounds stalled in the inflammatory phase, particularly chronic wounds that are "arrested in persistent inflammatory states" [1]. Necrotic tissue acts as a physical barrier to healing and a nidus for infection. However, a wound in the proliferative phase, by definition, has already cleared the necrotic burden and is actively filling with healthy granulation tissue. Debridement at this stage would mechanically disrupt new capillaries, fibroblasts, and fragile ECM, causing trauma and setting the healing process back.
Option 4: Apply cold therapy to reduce inflammation. Cold therapy causes vasoconstriction, which is directly counterproductive to the needs of the proliferative phase. This phase is critically dependent on angiogenesis and a rich blood supply to deliver oxygen and nutrients to the healing tissue [1]. Vasoconstriction would reduce this perfusion, causing local hypoxia and impairing cellular function. While cold therapy is useful in the immediate post-injury inflammatory phase to limit swelling, it is contraindicated during the tissue-building phase of a healing pressure ulcer.
The proliferative phase is a high-energy state requiring 30-35 kcal/kg/day and 1.25-1.5 g/kg/day of protein to support collagen synthesis and angiogenesis.
Key micronutrients include Vitamin C for collagen cross-linking, Zinc for protein synthesis, and Vitamin A to counteract steroid-induced healing suppression.
Do not apply cold therapy or excessive pressure to a healing stage 2 ulcer; vasoconstriction impairs the oxygen and nutrient delivery critical for granulation tissue survival.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.